Fecha de publicación: 15/11/2007 Fuente: WIPO "royal jelly" The present invention provides compositions and methods for preventing, ameliorating, treating, and/or rehabilitating from psychiatric conditions including attention-deficit/hyperactivity disorder (ADHD) and attention-deficit disorder (ADD), as well as compositions and methods for enhancing cognition. The compositions of the present invention, such as, a nutraceutical composition, or a pharmaceutical composition, may comprise RNA and optionally, an acetylcholine agent, royal jelly, and a nutraceutically or pharmaceutically acceptable carrier.